Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E 2 and cytokine release in human osteoarthritic synovial fibroblasts

Journal of Cellular Physiology

Volumn 227, Issue 6, 2012, Pages 2461-2469

  Ongaro, A ^a   Varani, K ^a   Masieri, F F ^a   Pellati, A ^a   Massari, L ^a   Cadossi, R ^b   Vincenzi, F ^a   Borea, P A ^a   Fini, M ^c   Caruso, A ^a   De Mattei, M ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b IGEA   (Italy)

^c RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 FURYL) 5 [3 (4 METHOXYPHENYL)UREIDO] 8 PROPYLPYRAZOLO[4,3 E] 1,2,4 TRIAZOLO[1,5 C]PYRIMIDINE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A2 RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; AGGRECANASE 1; AGGRECANASE 2; CL IB MECA; COLLAGENASE 3; CYCLIC AMP; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MRE 2029F20; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ELECTROMAGNETIC FIELD; ENZYME DEGRADATION; ENZYME SYNTHESIS; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MODULATION; NUCLEOTIDE SEQUENCE; OSTEOARTHRITIS; PRIORITY JOURNAL; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION; SYNOVIOCYTE; TREATMENT OUTCOME; UPREGULATION;

ADAM PROTEINS; ADULT; AGED; AGED, 80 AND OVER; CELLS, CULTURED; CYCLIC AMP; CYTOKINES; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROMAGNETIC FIELDS; FEMALE; FIBROBLASTS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; OSTEOARTHRITIS, HIP; PURINERGIC P1 RECEPTOR AGONISTS; PURINERGIC P1 RECEPTOR ANTAGONISTS; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1; RNA, MESSENGER; SYNOVIAL MEMBRANE;

EID: 84857472460     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22981     Document Type: Article

References (56)

1. Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K, Brown C, Cooke TD, Daniel W, Feldman D, et al. 1991. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 34:505-514.
2. Alvarez-Soria MA, Herrero-Beaumont G, Sanchez-Pernaute O, Bellido M, Largo R. 2008. Diacerein has a weak effect on the catabolic pathway of human osteoarthritis synovial fibroblast-comparison to its effects on osteoarthritic chondrocytes. Rheumatology (Oxford) 47:627-633.
3. Asano K, Sakai M, Matsuda T, Tanaka H, Fujii K, Hisamitsu T. 2006. Suppression of matrix metalloproteinase production from synovial fibroblasts by meloxicam in-vitro. J Pharm Pharmacol 58:359-366.
4. Benazzo F, Cadossi M, Cavani F, Fini M, Giavaresi G, Setti S, Cadossi R, Giardino R. 2008a. Cartilage repair with osteochondral autografts in sheep: Effect of biophysical stimulation with pulsed electromagnetic fields. J Orthop Res 26:631-642.
5. Benazzo F, Zanon G, Pederzini L, Modonesi F, Cardile C, Falez F, Ciolli L, La Cava F, Giannini S, Buda R, Setti S, Caruso G, Massari L. 2008b. Effects of biophysical stimulation in patients undergoing arthroscopic reconstruction of anterior cruciate ligament: Prospective, randomized and double blind study. Knee Surg Sports Traumatol Arthrosc 16:595-601.
6. Bondeson J, Wainwright SD, Lauder S, Amos N, Hughes CE. 2006. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis Res Ther 8:R187.
7. Burnstock G. 2008. Purinergic signalling and disorders of the central nervous system. Nat Rev Drug Discov 7:575-590.
8. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
9. Chang K, Chang WH, Huang S, Shih C. 2005. Pulsed electromagnetic fields stimulation affects osteoclast formation by modulation of osteoprotegerin, RANK ligand and macrophage colony-stimulating factor. J Orthop Res 23:1308-1314.
10. Cohen SB, Leo BM, Baer GS, Turner MA, Beck G, Diduch DR. 2005. An adenosine A2A receptor agonist reduces interleukin-8 expression and glycosaminoglycan loss following septic arthrosis. J Orthop Res 23:1172-1178.
11. Davidson RK, Waters JG, Kevorkian L, Darrah C, Cooper A, Donell ST, Clark IM. 2006. Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage. Arthritis Res Ther 8:R124.
12. De Mattei M, Caruso A, Pezzetti F, Pellati A, Stabellini G, Sollazzo V, Traina GC. 2001. Effects of pulsed electromagnetic fields on human articular chondrocyte proliferation. Connect Tissue Res 42:269-279.
13. De Mattei M, Pasello M, Pellati A, Stabellini G, Massari L, Gemmati D, Caruso A. 2003. Effects of electromagnetic fields on proteoglycan metabolism of bovine articular cartilage explants. Connect Tissue Res 44:154-159.
14. De Mattei M, Pellati A, Pasello M, Ongaro A, Setti S, Massari L, Gemmati D, Caruso A. 2004. Effects of physical stimulation with electromagnetic field and insulin growth factor-I treatment on proteoglycan synthesis of bovine articular cartilage. Osteoarthritis Cartilage 12:793-800.
15. De Mattei M, Fini M, Setti S, Ongaro A, Gemmati D, Stabellini G, Pellati A, Caruso A. 2007. Proteoglycan synthesis in bovine articular cartilage explants exposed to different low-frequency low-energy pulsed electromagnetic fields. Osteoarthritis Cartilage 15:163-168.
16. De Mattei M, Varani K, Masieri FF, Pellati A, Ongaro A, Fini M, Cadossi R, Vincenzi F, Borea PA, Caruso A. 2009. Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts. Osteoarthritis Cartilage 17:252-262.
17. Distler JH, Jungel A, Huber LC, Seemayer CA, Reich CF III, Gay RE, Michel BA, Fontana A, Gay S, Pisetsky DS, Distler O. 2005. The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proc Natl Acad Sci USA 102:2892-2897.
18. Fahmi H, He Y, Zhang M, Martel-Pelletier J, Pelletier JP, Di Battista JA. 2001. Nimesulide reduces interleukin-1beta-induced cyclooxygenase-2 gene expression in human synovial fibroblasts. Osteoarthritis Cartilage 9:332-340.
19. Fini M, Giavaresi G, Carpi A, Nicolini A, Setti S, Giardino R. 2005. Effects of pulsed electromagnetic fields on articular hyaline cartilage: Review of experimental and clinical studies. Biomed Pharmacother 59:388-394.
20. Gessi S, Merighi S, Varani K, Leung E, Mac Lennan S, Borea PA. 2008. The A3 adenosine receptor: An enigmatic player in cell biology. Pharmacol Ther 117:123-140.
21. Goldring MB, Goldring SR. 2007. Osteoarthritis. J Cell Physiol 213:626-634.
22. Gomez-Ochoa I, Gomez-Ochoa P, Gomez-Casal F, Cativiela E, Larrad-Mur L. 2010. Pulsed electromagnetic fields decrease proinflammatory cytokine secretion (IL-1beta and TNF-alpha) on human fibroblast-like cell culture. Rheumatol Int [Epub ahead of print].
23. Ham J, Rees DA. 2008. The adenosine a2b receptor: Its role in inflammation. Endocr Metab Immune Disord Drug Targets 8:244-254.
24. Huang K, Wu LD. 2008. Aggrecanase and aggrecan degradation in osteoarthritis: A review. J Int Med Res 36:1149-1160.
25. Huang TL, Hsu HC, Yang KC, Lin FH. 2011. Hyaluronan up-regulates IL-10 expression in fibroblast-like synoviocytes from patients with tibia plateau fracture. J Orthop Res 29:495-500.
26. Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. 2011. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 7:33-42.
27. Lee JY, Jhun BS, Oh YT, Lee JH, Choe W, Baik HH, Ha J, Yoon KS, Kim SS, Kang I. 2006. Activation of adenosine A3 receptor suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of PI 3-kinase/Akt and NF-kappaB activation in murine BV2 microglial cells. Neurosci Lett 396:1-6.
28. Lohmann CH, Schwartz Z, Liu Y, Guerkov H, Dean DD, Simon B, Boyan BD. 2000. Pulsed electromagnetic field stimulation of MG63 osteoblast-like cells affects differentiation and local factor production. J Orthop Res 18:637-646.
29. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
30. Lu HT, Liang YC, Sheu MT, Ho HO, Lin YT, Hsieh MS, Chen CH. 2008. Disease-modifying effects of glucosamine HCl involving regulation of metalloproteinases and chemokines activated by interleukin-1beta in human primary synovial fibroblasts. J Cell Biochem 104:38-50.
31. Mabley J, Soriano F, Pacher P, Hasko G, Marton A, Wallace R, Salzman A, Szabo C. 2003. The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5′-N-methyluronamide, is protective in two murine models of colitis. Eur J Pharmacol 466:323-329.
32. Marino AA, Kolomytkin OV, Frilot C. 2003. Extracellular currents alter gap junction intercellular communication in synovial fibroblasts. Bioelectromagnetics 24:199-205.
33. Martel-Pelletier J, Pelletier JP. 2010. Is osteoarthritis a disease involving only cartilage or other articular tissues? Eklem Hastalik Cerrahisi 21:2-14.
34. Martin L, Pingle SC, Hallam DM, Rybak LP, Ramkumar V. 2006. Activation of the adenosine A3 receptor in RAW 264.7cells inhibits lipopolysaccharide-stimulated tumor necrosis factor-alpha release by reducing calcium-dependent activation of nuclear factor-kappaB and extracellular signal-regulated kinase 1/2. J Pharmacol Exp Ther 316:71-78.
35. Munson PJ, Rodbard D. 1980. Ligand: A versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220-239.
36. Murray JC, Lacy M, Jackson SF. 1988. Degradative pathways in cultured synovial fibroblasts: Selective effects of pulsed electromagnetic fields. J Orthop Res 6:24-31.
37. Naganuma H, Sasaki A, Satoh E, Nagasaka M, Nakano S, Isoe S, Nukui H. 1998. Down-regulation of transforming growth factor-beta and interleukin-10 secretion from malignant glioma cells by cytokines and anticancer drugs. J Neurooncol 39:227-236.
38. Ochaion A, Bar-Yehuda S, Cohen S, Amital H, Jacobson KA, Joshi BV, Gao ZG, Barer F, Patoka R, Del Valle L, Perez-Liz G, Fishman P. 2008. The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-kappaB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats. Biochem Pharmacol 76:482-494.
39. Ongaro A, Stignani M, Pellati A, Melchiorri L, Massari L, Caruso G, De Mattei M, Caruso A, Baricordi OR, Rizzo R. 2010. Human leukocyte antigen-G molecules are constitutively expressed by synovial fibroblasts and upmodulated in osteoarthritis. Hum Immunol 71:342-350.
40. Ongaro A, Pellati A, Masieri FF, Caruso A, Setti S, Cadossi R, Biscione R, Massari L, Fini M, De Mattei M. 2011. Chondroprotective effects of pulsed electromagnetic fields on human cartilage explants. Bioelectromagnetics [Epub ahead of print].
41. Palmer TM, Trevethick MA. 2008. Suppression of inflammatory and immune responses by the A(2A) adenosine receptor: An introduction. Br J Pharmacol 153:S27-S34.
42. Pelletier JP, McCollum R, Cloutier JM, Martel-Pelletier J. 1995. Synthesis of metalloproteases and interleukin 6 (IL-6) in human osteoarthritic synovial membrane is an IL-1 mediated process. J Rheumatol Suppl 43:109-114.
43. Reboul P, Pelletier JP, Tardif G, Cloutier JM, Martel-Pelletier J. 1996. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. J Clin Invest 97:2011-2019.
44. Rohde C, Chiang A, Adipoju O, Casper D, Pilla AA. 2010. Effects of pulsed electromagnetic fields on interleukin-1 beta and postoperative pain: A double-blind, placebo-controlled, pilot study in breast reduction patients. Plast Reconstr Surg 125:1620-1629.
45. Sun HB, Yokota H. 2002. Reduction of cytokine-induced expression and activity of MMP-1 and MMP-13 by mechanical strain in MH7A rheumatoid synovial cells. Matrix Biol 21:263-270.
46. Tesch AM, MacDonald MH, Kollias-Baker C, Benton HP. 2002. Chondrocytes respond to adenosine via A(2)receptors and activity is potentiated by an adenosine deaminase inhibitor and a phosphodiesterase inhibitor. Osteoarthritis Cartilage 10:34-43.
47. Tesch AM, MacDonald MH, Kollias-Baker C, Benton HP. 2004. Endogenously produced adenosine regulates articular cartilage matrix homeostasis: Enzymatic depletion of adenosine stimulates matrix degradation. Osteoarthritis Cartilage 12:349-359.
48. Tortorella MD, Malfait AM, Deccico C, Arner E. 2001. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation. Osteoarthritis Cartilage 9:539-552.
49. Varani K, Merighi S, Gessi S, Klotz KN, Leung E, Baraldi PG, Cacciari B, Romagnoli R, Spalluto G, Borea PA. 2000. [(3)H]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors. Mol Pharmacol 57:968-975.
50. Varani K, Gessi S, Merighi S, Iannotta V, Cattabriga E, Spisani S, Cadossi R, Borea PA. 2002. Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. Br J Pharmacol 136:57-66.
51. Varani K, Gessi S, Merighi S, Iannotta V, Cattabriga E, Pancaldi C, Cadossi R, Borea PA. 2003. Alteration of A(3) adenosine receptors in human neutrophils and low frequency electromagnetic fields. Biochem Pharmacol 66:1897-1906.
52. Varani K, De Mattei M, Vincenzi F, Gessi S, Merighi S, Pellati A, Ongaro A, Caruso A, Cadossi R, Borea PA. 2008. Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields. Osteoarthritis Cartilage 16:292-304.
53. 2B receptors. Biochem Pharmacol 70:1601-1612.
54. Varani K, Vincenzi F, Tosi A, Targa M, Masieri FF, Ongaro A, De Mattei M, Massari L, Borea PA. 2010. Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes. Br J Pharmacol 160:101-115.
55. Wang CT, Lin YT, Chiang BL, Lin YH, Hou SM. 2006. High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. Osteoarthritis Cartilage 14:1237-1247.
56. Zorzi C, Dall'Oca C, Cadossi R, Setti S. 2007. Effects of pulsed electromagnetic fields on patients' recovery after arthroscopic surgery: Prospective, randomized and double-blind study. Knee Surg Sports Traumatol Arthrosc 15:830-834.